
Cidofovir dihydrate
CAS No. 149394-66-1
Cidofovir dihydrate ( HPMPC dihydrate | (S)-HPMPC dihydrate )
产品货号. M12069 CAS No. 149394-66-1
西多福韦二磷酸酯的前药,通过选择性抑制病毒 DNA 聚合酶来抑制巨细胞病毒 (CMV) 病毒复制。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥405 | 有现货 |
![]() ![]() |
10MG | ¥608 | 有现货 |
![]() ![]() |
25MG | ¥1037 | 有现货 |
![]() ![]() |
50MG | ¥1555 | 有现货 |
![]() ![]() |
100MG | ¥2325 | 有现货 |
![]() ![]() |
200MG | ¥3491 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Cidofovir dihydrate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述西多福韦二磷酸酯的前药,通过选择性抑制病毒 DNA 聚合酶来抑制巨细胞病毒 (CMV) 病毒复制。
-
产品描述The prodrug of cidofovir diphosphate that inhibits cytomegalovirus (CMV) viral replication by selectively inhibiting viral DNA polymerases; also incorporates itself into viral DNA hence inhibiting viral DNA synthesis during reproduction.CMV Infection Approved.
-
体外实验Cidofovir (5-100 μM, 72 hours) dihydrate has antiviral activity against feline herpesvirus type-1 (FHV-1) with an IC50 of 11 μM, and can reduce Crandell-Reese feline kidney cells counts in a dose dependent manner. Cidofovir (10-1000 μM, 24-120 hours) dihydrate can reduce cancer cell viability and induces apoptosis.Cell Cytotoxicity Assay Cell Line:Crandell-Reese feline kidney(CRFK) cellsConcentration:10-100 μM Incubation Time:72 hours Result:Reduced CRFK cells by 9.1%.Cell Viability Assay Cell Line:Caco-2, FTC-133, HeLa, Hep-G2, MDA-MB-231, NCI-H1975 and PC-3 cells Concentration:10-1000 μM Incubation Time:24, 48, 72, 96, 120 hours Result:Resulted in a gradual decrease in tumor cell viability with time and concentration increasing and inhibited the number of FTC-133 cell clones by about 55% at 100 μM comparing to the untreated group.Apoptosis Analysis Cell Line:FTC-133 cells Concentration:100 μM Incubation Time:96 hours Result:Showed a significant increase in the expression of pro-apoptotic proteins, such as cytochrome c, phospho-p53 (S15) and caspase-3 by 130%, 49%, and 46%, respectively while the anti-apoptotic protein Bcl-x decreased significantly by 57% comparing to the untreated cells.
-
体内实验Cidofovir (subcutaneous injection, 100 mg/kg, 3-6 days interval, 21 days)dihydrate is highly protective against death from cowpox virus (CPV) infection at high doses in female weanling BALB/c mice. Animal Model:Female weanling BALB/c mice infected with cowpox virus (CPV)Dosage:100 mg/kg Administration:Subcutaneous injection; 3-6 days interval; 21 days Result:Prevented 80-100% of mouse deaths when administered on the first 4-3 days before infection.Protected 35-50% of mice when administered on the fourth day after infection, and 10-20% when administered on the sixth day.
-
同义词HPMPC dihydrate | (S)-HPMPC dihydrate
-
通路Microbiology/Virology
-
靶点CMV
-
受体CMV
-
研究领域Infection
-
适应症CMV Infection
化学信息
-
CAS Number149394-66-1
-
分子量315.2176
-
分子式C8H18N3O8P
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESC1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O.O.O
-
化学全称Phosphonic acid, P-[[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, hydrate (1:2)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册




关联产品
-
Brincidofovir
Brincidofovir(CMX 001;Cidofovir HDP)是无环核苷酸磷酸酯的脂质缀合物。
-
GW 275175X
GW 275175X 是 BDCRB 的衍生物,通过抑制病毒 DNA 成熟而表现出抗 HCMV 活性。
-
CFI02
CFI02 (CFI-02) 是人巨细胞病毒 (HCMV) 糖蛋白 B 介导的融合的特异性抑制剂,针对实验室适应的 HCMV 毒株 AD169,IC50 为 40 nM。